Veralox Success Story

Veralox Success Story

FREDERICK, Md.Aug. 31, 2018 /PRNewswire-PRWeb/ — Rare blood disorders are on VERALOX Therapeutics Inc.’s “hit” list. The company, a small molecule drug discovery and development firm based in the Frederick Innovative Technology Center, Inc. (FITCI), launched in September 2017 with a mission to develop a first-in-class therapeutic targeting rare immune-mediated blood disorders, beginning with heparin-induced thrombocytopenia (HIT) and HIT with thrombosis (HITT).

URL link to full story
https://markets.businessinsider.com/news/stocks/frederick-innovative-technology-center-inc-success-story-1027499893
Media Contact
Dave Maloney
2402434049
Comments are closed.